108 related articles for article (PubMed ID: 3613794)
1. Treatment of invasive Aspergillus sinusitis with liposomal-amphotericin B.
Weber RS; Lopez-Berestein G
Laryngoscope; 1987 Aug; 97(8 Pt 1):937-41. PubMed ID: 3613794
[TBL] [Abstract][Full Text] [Related]
2. Treatment of invasive fungal sinusitis with liposomal amphotericin B: a report of four cases.
Sungkanuparph S; Sathapatayavongs B; Kunachak S; Luxameechanporn T; Cheewaruangroj W
J Med Assoc Thai; 2001 Apr; 84(4):593-601. PubMed ID: 11460976
[TBL] [Abstract][Full Text] [Related]
3. [Remission of invasive sinusal and pulmonary aspergillosis with liposomal amphotericin B in a patient with chronic lymphatic leukemia following failure with conventional amphotericin].
Palacio C; Acebedo G; López A; Jodar JM
Sangre (Barc); 1994 Oct; 39(5):389-92. PubMed ID: 7754445
[TBL] [Abstract][Full Text] [Related]
4. Treatment of systemic fungal infections with liposomal amphotericin B.
Lopez-Berestein G; Bodey GP; Fainstein V; Keating M; Frankel LS; Zeluff B; Gentry L; Mehta K
Arch Intern Med; 1989 Nov; 149(11):2533-6. PubMed ID: 2818111
[TBL] [Abstract][Full Text] [Related]
5. Liposomal amphotericin B in three lung transplant recipients. The Groningen Lung Transplantation Group.
Mannes GP; van der Bij W; de Boer WJ
J Heart Lung Transplant; 1995; 14(4):781-4. PubMed ID: 7578189
[TBL] [Abstract][Full Text] [Related]
6. Amphotericin B lipid complex versus liposomal amphotericin B monotherapy for invasive aspergillosis in patients with hematologic malignancy.
Hachem RY; Boktour MR; Hanna HA; Husni RN; Torres HA; Afif C; Kontoyiannis DP; Raad II
Cancer; 2008 Mar; 112(6):1282-7. PubMed ID: 18224662
[TBL] [Abstract][Full Text] [Related]
7. Liposomal amphotericin B for the treatment of systemic fungal infections in patients with cancer: a preliminary study.
Lopez-Berestein G; Fainstein V; Hopfer R; Mehta K; Sullivan MP; Keating M; Rosenblum MG; Mehta R; Luna M; Hersh EM
J Infect Dis; 1985 Apr; 151(4):704-10. PubMed ID: 3973417
[TBL] [Abstract][Full Text] [Related]
8. Successful treatment of invasive Aspergillus rhinosinusitis in a child with acute myeloid leukemia.
Jaing TH; Yang CP; Hung IJ; Chiu CH; Hsueh C
J Otolaryngol; 2000 Aug; 29(4):257-9. PubMed ID: 11003082
[No Abstract] [Full Text] [Related]
9. Liposomal amphotericin B (AmBisome) therapy in invasive fungal infections. Evaluation of United Kingdom compassionate use data.
Ng TT; Denning DW
Arch Intern Med; 1995 May; 155(10):1093-8. PubMed ID: 7748054
[TBL] [Abstract][Full Text] [Related]
10. Amphotericin B lipid complex in the management of invasive aspergillosis in immunocompromised patients.
Chandrasekar PH; Ito JI
Clin Infect Dis; 2005 May; 40 Suppl 6():S392-400. PubMed ID: 15809925
[TBL] [Abstract][Full Text] [Related]
11. Aggressive combination treatment for invasive fungal sinusitis in immunocompromised patients.
Rizk SS; Kraus DH; Gerresheim G; Mudan S
Ear Nose Throat J; 2000 Apr; 79(4):278-80, 282, 284-5. PubMed ID: 10786391
[TBL] [Abstract][Full Text] [Related]
12. Invasive fungal sinusitis in patients undergoing bone marrow transplantation.
Drakos PE; Nagler A; Or R; Naparstek E; Kapelushnik J; Engelhard D; Rahav G; Ne'emean D; Slavin S
Bone Marrow Transplant; 1993 Sep; 12(3):203-8. PubMed ID: 8241977
[TBL] [Abstract][Full Text] [Related]
13. The novel lipid delivery system of amphotericin B: drug profile and relevance to clinical practice.
Rust DM; Jameson G
Oncol Nurs Forum; 1998; 25(1):35-48. PubMed ID: 9460772
[TBL] [Abstract][Full Text] [Related]
14. Successful treatment with micafungin of invasive pulmonary aspergillosis in acute myeloid leukemia, with renal failure due to amphotericin B therapy.
Yokote T; Akioka T; Oka S; Fujisaka T; Yamano T; Hara S; Tsuji M; Hanafusa T
Ann Hematol; 2004 Jan; 83(1):64-6. PubMed ID: 14661114
[TBL] [Abstract][Full Text] [Related]
15. Invasive subglottal aspergillosis in a patient with severe aplastic anemia: a case report.
Nagasawa M; Itoh S; Tomizawa D; Kajiwara M; Sugimoto T; Kumagai J
J Infect; 2002 Apr; 44(3):198-201. PubMed ID: 12099752
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of amphotericin B lipid complex (ABLC) treatment in allogeneic hematopoietic cell transplant (HCT) recipients with invasive aspergillosis (IA).
Ito JI; Chandrasekar PH; Hooshmand-Rad R
Bone Marrow Transplant; 2005 Nov; 36(10):873-7. PubMed ID: 16113663
[TBL] [Abstract][Full Text] [Related]
17. [Liposome amphotericin in the treatment of deep mycoses in patients not severely immunosuppressed. An efficient alternative with low toxicity].
Fernández B de Quirós J; Telenti M; Fernández Castro A; Mateos V; Arnáez Moral E
Med Clin (Barc); 1993 Oct; 101(11):421-3. PubMed ID: 8231358
[TBL] [Abstract][Full Text] [Related]
18. Liposomal amphotericin B for the treatment of severe fungal infection.
Michaud D
Dynamics; 2001; 12(1):17-21. PubMed ID: 11982230
[TBL] [Abstract][Full Text] [Related]
19. Combination antifungal therapy for invasive aspergillosis: can it replace high-risk surgery at the skull base?
Panda NK; Saravanan K; Chakrabarti A
Am J Otolaryngol; 2008; 29(1):24-30. PubMed ID: 18061828
[TBL] [Abstract][Full Text] [Related]
20. Aspergillus susceptibility testing in patients with cancer and invasive aspergillosis: difficulties in establishing correlation between in vitro susceptibility data and the outcome of initial amphotericin B therapy.
Lionakis MS; Lewis RE; Chamilos G; Kontoyiannis DP
Pharmacotherapy; 2005 Sep; 25(9):1174-80. PubMed ID: 16164392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
